Polymyxin B sulfate and trimethoprim (PBT) are two antibiotics used to treat a wide range of bacterial infections. PBT has been in use for more than 40 years, and is now the most commonly prescribed antibiotic combination in the United States. PBT is effective against most Gram-positive and Gram-negative bacteria, and has been used to treat a variety of infections, including urinary tract infections, skin and soft tissue infections, and respiratory tract infections. In this comprehensive guide, we will discuss the indications, pharmacology, and clinical use of PBT, as well as potential adverse effects and drug interactions.
PBT is indicated for the treatment of a wide range of bacterial infections, including urinary tract infections, skin and soft tissue infections, and respiratory tract infections. It is also approved for the treatment of certain sexually transmitted diseases, including gonorrhea and chlamydia. PBT is also used off-label to treat a variety of other infections, including meningitis, endocarditis, and sepsis.
PBT is a combination of two antibiotics, polymyxin B sulfate and trimethoprim. Polymyxin B is a polypeptide antibiotic derived from the bacterium Bacillus polymyxa. It works by binding to the outer membrane of Gram-negative bacteria, causing disruption of the cell membrane and leakage of intracellular components. Trimethoprim is a synthetic antibiotic that inhibits the synthesis of dihydrofolate reductase, an enzyme involved in the synthesis of folate, a cofactor for the synthesis of nucleic acids. By inhibiting the synthesis of folate, trimethoprim interferes with the synthesis of nucleic acids, preventing bacterial replication.
PBT is generally well tolerated and is effective against most Gram-positive and Gram-negative bacteria, including many resistant strains. It is usually administered orally, although it can also be administered intravenously. The usual dose is one tablet (500mg polymyxin B sulfate and 200mg trimethoprim) taken twice daily for seven to ten days. The dose may need to be adjusted for patients with renal impairment.
As with any medication, PBT can cause adverse effects. The most common side effects include nausea, vomiting, diarrhea, and rash. Other more serious side effects, such as anaphylaxis and Stevens-Johnson syndrome, have been reported in rare cases. PBT can also interact with other medications, including antacids, diuretics, and warfarin. It is important to tell your doctor about all medications you are taking before starting PBT.
Polymyxin B sulfate and trimethoprim (PBT) is a combination antibiotic used to treat a wide range of bacterial infections. It is generally well tolerated and is effective against most Gram-positive and Gram-negative bacteria, including many resistant strains. While PBT is generally safe and effective, it can cause adverse effects and interact with other medications, so it is important to tell your doctor about all medications you are taking before starting PBT. With proper use, PBT can be a powerful tool in the fight against bacterial infections.
1.
Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC
2.
When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?
3.
Independent Risk Factors for "Deaths of Despair" Found.
4.
Except for Black Patients, the Rates of Gallbladder Cancer Are Stable or Declining.
5.
Risk of a second cancer after early breast cancer is low, say new findings
1.
Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors
2.
HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways
3.
Tumor Microenvironment Reprogramming for Regenerative Cancer Recovery
4.
Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes
5.
Secure Computational Infrastructure for Collaborative Multicenter Oncology Research Without Centralizing Patient Data
1.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Symposium on Oncology, Cardiology and Critical Care Innovations
4.
International Conference on Cancer Nursing and Hematology Support
5.
International Conference on Clinical Medicine and Surgical Care
1.
Advances in Modern Cancer Treatment
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Understanding Anemia and Its Common Causes
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation